According to Nova one advisor, the global Interspinous Spacers market size was valued at USD 71.20 million in 2021 and is predicted to hit USD 127.40 million by 2030 with a registered CAGR of 6.10% during the forecast period 2022 to 2030.
Interspinous spacer is a device implanted between two interspinous processes to create space between nerve channels. This procedure is used as a minimally invasive surgery alternative to surgical procedures used to decompress the spinal canal. Spinal stenosis is most commonly caused by wear and tear in the spine due to osteoarthritis. In severe cases of spinal stenosis, doctors recommend minimally invasive surgery to create additional space for the spinal cord or nerves. Various organizations such as the World Health Organization (WHO) and Population Reference Bureau indicate that the percentage of population aged above 50 is increasing at a steady pace compared to the geriatric population. A report published by WHO revealed that the number of people aged 65 years or older is expected to increase from 605 million in 2012 to 2 billion by 2050. Moreover, the Population Reference Bureau (PRB) suggested that the geriatric population in regions such as Europe and Asia Pacific is rising rapidly compared to other developed or developing regions due to low fertility rate. Innovative product launches and their commercialization across the globe are anticipated to augment the global interspinous spacers market. Globally, physicians and surgeons are opting for minimally invasive surgery for spinal pain management. These procedures are gaining popularity over conventional surgeries, such as spinal fusion procedures, in the treatment of LSS, degenerative disc disease, and other related disorders.
Report Scope of the Interspinous Spacers Market
Report Coverage |
Details |
Market Size |
USD 127.40 Billion by 2030 |
Growth Rate |
CAGR of 6.10% from 2022 to 2030 |
Largest Market |
North America |
Fastest Growing Market |
Asia Pacific |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Interspinous Spacers, Indication, End-user, and Region, |
Companies Mentioned |
|
COVID-19 Impact on Interspinous Spacers Market
The COVID-19 pandemic has had a negative impact on the global interspinous spacers market. Governments of affected countries deferred non-essential surgeries and patient visits during the breakout year of COVID-19. Several ICU facilities, such as ventilators, personal protective equipment, and medical staff, were rerouted to COVID-19 cases, prompting the suspension of spinal surgery during the pandemic. This led to substantial decline in overall non-emergency surgeries and treatments, which in turn restricted the usage of vertiflex spacers in spinal pain management. Key players reported decline in revenue due to the pandemic, which led to a decrease in Y-o-Y market share in the interspinous spacers market. However, the market has recovered from COVID-19 due to easing of restrictions by countries across the globe.
Low Cost and New Product Launches Driving Static Segment
The static segment accounted for major market share for interspinous spacers in 2021. Low cost of static spacers, product launches, and favorable reimbursement policies are anticipated to augment the segment during the forecast period. For instance, in April 2022, Spinal Simplicity, a medical device company, announced the launch of the Minuteman G5 implant. Minuteman is a minimally invasive, interspinous interlaminar fusion device intended for the fixation and stabilization of the thoracic, lumbar, and sacral spine, while awaiting bony fusion to occur. Static interspinous spacers are the primary choice of surgeons owing to their multiple advantages such as low cost spacers. Reports claim that over 11,000 X STOP implants have been inserted worldwide, since X STOP received approval from the U.S. Food and Drug Administration (FDA).
Increase in Geriatric Population Propelling Lumbar Spinal Stenosis Segment
In terms of indication, the lumbar spinal stenosis segment is projected to dominate the global market during the forecast period. Increase in geriatric population, high prevalence of LSS among the population aged above 60, and high adoption of minimally invasive surgery procedures are the factors likely to drive the segment during the forecast period. For instance, 250,000 to 500,000 U.S. residents are affected by symptoms of spinal stenosis. This indicates that around 1 in 1,000 people older than 65 years and 5 in 1,000 people older than 50 years of age are affected with spinal stenosis. LSS is the leading preoperative diagnosis for adults older than 65 who undergo spine surgery. According to a United Nations report, around 128 million people in China are above 60 years of age, which is higher than Japan’s entire population. By the end of 2050, China could have around 400 million people aged above 60 years. Hence, surge in the geriatric population is likely to increase the prevalence of LSS.
Regional Outlook of Global Interspinous Spacers Market
North America is projected to be a highly lucrative region of the global market during the forecast period. The region accounted for the largest share of the global market in 2021. High prevalence of degenerative disc disorders and spinal stenosis; and presence of technologically advanced countries are the factors propelling the market in North America. The U.S. dominates the market in North America and is anticipated to sustain its leadership position during the forecast period due to large number of patients with degenerative disc disorders and favorable reimbursement for interspinous spacer devices. Additionally, increase in LSS in the geriatric population is driving the demand for interspinous spacers in the U.S.
Europe was the second-largest interspinous spacers market in 2021. Favorable regulatory and reimbursement scenario, approval of products, and presence of large geriatric population and people with spine disabilities are likely to propel the interspinous spacers market in the region.
The market in Asia Pacific is projected to grow at a significantly high CAGR during the forecast period owing to the increase in geriatric population in countries such as Japan and China, higher incidence rates of LSS & degenerative disc diseases, rise in per capita income, and improving healthcare infrastructure. Moreover, growth in healthcare expenditure and rise in investments by key players in the interspinous spacers market in emerging economies are expected to propel the market in the region.
Key Developments in Global Interspinous Spacers Market
Some of the prominent players in the Interspinous Spacers Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Interspinous Spacers market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders